原癌基因FRAT1抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 原癌基因FRAT1抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significant homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) 原癌基因FRAT1抗体binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates 原癌基因FRAT1抗体and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins.

原癌基因FRAT1抗体Also known as:

FRAT 1; frequently rearranged in advanced T cell lymphomas; Frequently rearranged in advanced T-cell lymphomas; GSK 3 binding protein FRAT1; proto oncogene FRAT1; FRAT1_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Cow, .

●

Immunogen: KLH conjugated synthetic peptide derived from human FRAT1.

●

Predicted Molecular Weight: 29kDa.

原癌基因FRAT1抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl263Mu01精氨酸加压素受体1B(AVPR1B)多克隆抗体Polyclonal Antibody to Arginine Vasopressin Receptor 1B (AVPR1B)

kl265Hu01胰多肽(PP)多克隆抗体Polyclonal Antibody to klcreatic Polypeptide (PP)

kl265Mu01胰多肽(PP)多克隆抗体Polyclonal Antibody to klcreatic Polypeptide (PP)

kl266Ga01胰高血糖素(GC)多克隆抗体Polyclonal Antibody to Glucagon (GC)

kl267Hu01激肽原1(KNG1)多克隆抗体Polyclonal Antibody to Kininogen 1 (KNG1)

kl267Mu01激肽原1(KNG1)多克隆抗体Polyclonal Antibody to Kininogen 1 (KNG1)

kl267Ra01激肽原1(KNG1)多克隆抗体Polyclonal Antibody to Kininogen 1 (KNG1)

kl268Hu01苯酚磺基转移酶(PST)多克隆抗体Polyclonal Antibody to Phenol Sulfotransferase (PST)

kl268Mu01苯酚磺基转移酶(PST)多克隆抗体Polyclonal Antibody to Phenol Sulfotransferase (PST)

kl271Hu01IgG-Fc片段低亲和力受体Ⅲb(FcγR3B)多克隆抗体Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIb Receptor (FcgR3B)

kl273Hu01孕酮受体(PGR)多克隆抗体Polyclonal Antibody to Progesterone Receptor (PGR)

kl275Hu01膜辅蛋白(MCP)多克隆抗体Polyclonal Antibody to Membrane Cofactor Protein (MCP)

kl276Hu01激素敏感性脂肪酶(LIPE)多克隆抗体Polyclonal Antibody to Likle, Hormone Sensitive (LIPE)

kl276Ra01激素敏感性脂肪酶(LIPE)多克隆抗体Polyclonal Antibody to Likle, Hormone Sensitive (LIPE)

kl277Hu01脑型脂肪酸结合蛋白(FABP7)多克隆抗体Polyclonal Antibody to Fatty Acid Binding Protein 7, Brain (FABP7)

kl278Hu01IgG-Fc片段低亲和力受体Ⅲa(FcγR3A)多克隆抗体Polyclonal Antibody to Fc Fragment Of IgG Low Affinity IIIa Receptor (FcgR3A)

kl280Bo01组织蛋白酶D(CTSD)多克隆抗体Polyclonal Antibody to Cathepsin D (CTSD)

kl280Hu01组织蛋白酶D(CTSD)多克隆抗体Polyclonal Antibody to Cathepsin D (CTSD)

kl280Mu01组织蛋白酶D(CTSD)多克隆抗体Polyclonal Antibody to Cathepsin D (CTSD)